1. Home
  2. BIOX vs ESPR Comparison

BIOX vs ESPR Comparison

Compare BIOX & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIOX
  • ESPR
  • Stock Information
  • Founded
  • BIOX 2001
  • ESPR 2008
  • Country
  • BIOX Argentina
  • ESPR United States
  • Employees
  • BIOX N/A
  • ESPR N/A
  • Industry
  • BIOX Agricultural Chemicals
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BIOX Industrials
  • ESPR Health Care
  • Exchange
  • BIOX Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • BIOX 275.1M
  • ESPR 305.0M
  • IPO Year
  • BIOX N/A
  • ESPR 2013
  • Fundamental
  • Price
  • BIOX $4.11
  • ESPR $1.21
  • Analyst Decision
  • BIOX Strong Buy
  • ESPR Buy
  • Analyst Count
  • BIOX 4
  • ESPR 7
  • Target Price
  • BIOX $9.88
  • ESPR $6.36
  • AVG Volume (30 Days)
  • BIOX 257.9K
  • ESPR 4.6M
  • Earning Date
  • BIOX 05-12-2025
  • ESPR 05-06-2025
  • Dividend Yield
  • BIOX N/A
  • ESPR N/A
  • EPS Growth
  • BIOX N/A
  • ESPR N/A
  • EPS
  • BIOX 0.02
  • ESPR N/A
  • Revenue
  • BIOX $407,732,105.00
  • ESPR $332,314,000.00
  • Revenue This Year
  • BIOX N/A
  • ESPR $5.17
  • Revenue Next Year
  • BIOX $7.55
  • ESPR N/A
  • P/E Ratio
  • BIOX $190.15
  • ESPR N/A
  • Revenue Growth
  • BIOX N/A
  • ESPR 185.66
  • 52 Week Low
  • BIOX $3.69
  • ESPR $1.28
  • 52 Week High
  • BIOX $13.18
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • BIOX 37.50
  • ESPR 28.01
  • Support Level
  • BIOX $4.31
  • ESPR $1.35
  • Resistance Level
  • BIOX $4.63
  • ESPR $1.75
  • Average True Range (ATR)
  • BIOX 0.37
  • ESPR 0.09
  • MACD
  • BIOX 0.00
  • ESPR -0.03
  • Stochastic Oscillator
  • BIOX 0.00
  • ESPR 4.81

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: